These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3575750)

  • 1. Cell-specific pathology in neural systems of the temporal lobe in Alzheimer's disease.
    Van Hoesen GW; Hyman BT; Damasio AR
    Prog Brain Res; 1986; 70():321-35. PubMed ID: 3575750
    [No Abstract]   [Full Text] [Related]  

  • 2. Measures of medial temporal lobe atrophy in Alzheimer's disease.
    Frisoni GB; Bianchetti A; Geroldi C; Trabucchi M; Beltramello A; Weiss C
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1438-9. PubMed ID: 7964833
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus.
    Connor B; Beilharz EJ; Williams C; Synek B; Gluckman PD; Faull RL; Dragunow M
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):283-90. PubMed ID: 9387889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetry of pathology in Alzheimer's disease.
    Wilcock GK; Esiri MM
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1384-6. PubMed ID: 3681321
    [No Abstract]   [Full Text] [Related]  

  • 5. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease.
    Erkinjuntti T; Lee DH; Gao F; Steenhuis R; Eliasziw M; Fry R; Merskey H; Hachinski VC
    Arch Neurol; 1993 Mar; 50(3):305-10. PubMed ID: 8442711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
    Visser PJ; Verhey FR; Hofman PA; Scheltens P; Jolles J
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):491-7. PubMed ID: 11909909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease.
    Hanyu H; Sakurai H; Iwamoto T; Takasaki M; Shindo H; Abe K
    J Neurol Sci; 1998 Apr; 156(2):195-200. PubMed ID: 9588857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
    Korf ES; Scheltens P; Barkhof F; de Leeuw FE
    Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):310-2. PubMed ID: 3958743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetry of pathology in Alzheimer's disease.
    Janota I; Mountjoy CQ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):1011-2. PubMed ID: 3204396
    [No Abstract]   [Full Text] [Related]  

  • 11. Laminar neuropathology in Alzheimer's disease by a modified Gallyas impregnation.
    Heinsen H; Beckmann H; Heinsen YL; Gallyas F; Haas S; Scharff G
    Psychiatry Res; 1989 Sep; 29(3):463-5. PubMed ID: 2481861
    [No Abstract]   [Full Text] [Related]  

  • 12. Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia.
    Chan D; Fox N; Rossor M
    Neurology; 2002 Mar; 58(5):838. PubMed ID: 11889267
    [No Abstract]   [Full Text] [Related]  

  • 13. The temporal lobe in dementia of Alzheimer's type.
    Wilcock GK
    Gerontology; 1983; 29(5):320-4. PubMed ID: 6618185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Sci; 1985 Jul; 69(3):139-59. PubMed ID: 3162000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.
    Davis PC; Gearing M; Gray L; Mirra SS; Morris JC; Edland SD; Lin T; Heyman A
    Neurology; 1995 Jan; 45(1):178-9. PubMed ID: 7824112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal lobe pathology in amyotrophic lateral sclerosis. Do amyotrophic lateral sclerosis and Alzheimer's disease share a common etiological factor?
    Smitt PA; Troost D; Louwerse ES; de Jong JM; van Kessel DT; de Leeuw MA
    Clin Neuropathol; 1993; 12(2):88-91. PubMed ID: 8477553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease.
    Chan D; Fox NC; Scahill RI; Crum WR; Whitwell JL; Leschziner G; Rossor AM; Stevens JM; Cipolotti L; Rossor MN
    Ann Neurol; 2001 Apr; 49(4):433-42. PubMed ID: 11310620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease.
    Jobst KA; Smith AD; Szatmari M; Esiri MM; Jaskowski A; Hindley N; McDonald B; Molyneux AJ
    Lancet; 1994 Apr; 343(8901):829-30. PubMed ID: 7908080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background.
    Giannakopoulos P; Gold G; Michel JP; Bouras C
    Ann Med Interne (Paris); 1998 Jun; 149(4):187-91. PubMed ID: 11490545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.